Cite
MLA Citation
Andrew J. Wagner et al.. “Dose-escalation study of a second-generation non-ansamycin HSP90 inhibitor, onalespib (AT13387), in combination with imatinib in patients with metastatic gastrointestinal stromal tumour.” European journal of cancer, vol. 61, 2016, pp. 94–101. http://access.bl.uk/ark:/81055/vdc_100039064995.0x00001c